A Study of PRT-201 Administered Immediately After Radiocephalic Arteriovenous Fistula(AVF) Creation in Patients With Chronic Kidney Disease (CKD) (PATENCY-1)

PHASE3CompletedINTERVENTIONAL
Enrollment

349

Participants

Timeline

Start Date

July 31, 2014

Primary Completion Date

December 31, 2016

Study Completion Date

December 31, 2018

Conditions
Chronic Kidney Disease
Interventions
DRUG

PRT-201

DRUG

Placebo

Trial Locations (35)

10029

Mount Sinai Medical Center, New York

15240

VA Pittsburg Healthcare System, Pittsburgh

18103

Lehigh Valley Health Network, Allentown

21201

University of Maryland, Baltimore

21601

University of Maryland Shore Medical Center at Easton, Easton

27157

Wake Forest, Winston-Salem

27599

University of North Carolina at Chapel Hill, Chapel Hill

27710

Duke University, Durham

28144

W.G. Hefner VA Medical Center, Salisbury

35294

University of Alabama at Birmingham, Birmingham

40202

University of Louisville, Louisville

43210

Ohio State University, Columbus

45267

University of Cincinnati Medical Center, Cincinnati

University of Cincinnati, Cincinnati

46804

Lutheran Hospital Network of Indiana, Fort Wayne

52242

University of Iowa Hospitals and Clinics, Iowa City

60612

Rush Medical Center, Chicago

61603

Renal Care Associates, Peoria

70112

Tulane University, New Orleans

71130

Louisiana State University Health Sciences Center, Shreveport

74104

The University of Oklahoma College of Medicine, Tulsa

77030

The Methodist Hospital, Houston

85012

AKDHC Medical Research Services , LLC, Phoenix

85719

AKDHC Medical Research Services, LLc, Tucson

90033

Keck University Hospital at USC, Los Angeles

90822

VA Medical Center Long Beach, Long Beach

92120

Kaiser Permanente Medical Center, San Diego

92123

California Institute of Renal Research, San Diego

92653

Alliance Research Center, Laguna Hills

94143

UCSF Division of Vascular & Endovascular Surgery, San Francisco

98004

Lake Washington Vascular Center, Bellevue

04102

Maine Medical Center, Portland

02215

Beth Israel Deaconess Medical Center, Boston

02482

Brigham and Women's Hospital, Boston

01655

University of Massachusetts Medical Center, Worcester

Sponsors
All Listed Sponsors
lead

Proteon Therapeutics

INDUSTRY